University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis

Q: How long will it take to read this news story?

The story "University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis" has 1703 words across 43 sentences, which will take approximately 8 - 15 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis" was covered 11 hours ago by TechCrunch, a news publisher based in United States.

Q: How trustworthy is 'TechCrunch' news outlet?

TechCrunch is a fully independent (privately-owned) news outlet established in 2005 that covers mostly technology news. The outlet is headquartered in United States and publishes an average of 30 news stories per day. It's most recent story was published 8 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Positive, indicating that people regard this as "good news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #26440668</li><li>URL: https://beamstart.com/news/university-spin-out-afynia-secures-17405034943478</li></ul>

TechCrunch 11h ago

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis - TechCrunch

Quick Summary:

Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in seed funding to commercialize a blood test for endometriosis — a medical condition that can afflict people with a uterus, causing problems like chronic pelvic pain and fertility issues.

Endometriosis affects nearly 200 million people worldwide.

Competitors also chasing the promise of non-invasive testing for female health issues include the likes of California’s NextGen Jane, which is exploring using menstrual blood collected via tampons to test for endometriosis and other health conditions; and DotLab, another U.S.player, that’s developed a blood-based test for endometriosis.